Chronic Pain and Addiction

Editor(s): Clark M.R. (Baltimore, Md.) 
Treisman G.J. (Baltimore, Md.) 
Table of Contents
Vol. 30, 2011
Section title: Paper
Clark MR, Treisman GJ (eds): Chronic Pain and Addiction. Adv Psychosom Med. Basel, Karger, 2011, vol 30, pp 61–91

Opioid Therapy in Patients with Chronic Noncancer Pain: Diagnostic and Clinical Challenges

Cheatle M.D. · O’Brien C.P.
Center for Studies of Addiction, Department of Psychiatry, University of Pennsylvania, Philadelphia, Pa., USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Chronic opioid therapy for patients with chronic noncancer pain has become controversial, given the rising prevalence of opioid abuse. The prevailing literature suggests that the rate of addiction in chronic noncancer pain patients exposed to opioid therapy is relatively low, especially in those patients without significant concomitant psychiatric disorders and personal and family history of addiction. However, the escalating rate of misuse of prescription opioids has resulted in many clinicians caring for these patients to be more judicious in prescribing opioids. Accurately diagnos ing addiction in chronic pain patients receiving opioids is complex. Managing the patient with pain and co-occurring opioid abuse is equally challenging. Diagnostic issues, current guidelines for the appropriate use of opioids in the chronic pain population and risk stratification models are examined. Pharmacologic and nonpharmacologic treatment strategies for the patient with pain and opioid addiction are reviewed.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Portenoy RK Ugarte C Fuller I Haas G: Population-based surveys of pain in the United States: differences among white, African American, and Hispanic subjects. J Pain 2004; 5: 317-328
  2. Pleis JR Lucas JW Ward BW: Summary health statistics for US adults: National Health Interview Survey, 2008. Vital Health Stat 10 2009; 1-157
  3. Stewart W Ricci J Chee E Morganstein D Lipton R: Lost productive time and cost due to common pain conditions in the US workforce. JAMA 2003; 290: 2443-2454
  4. White AG Birnbaum HG Mareva MN Daher M Vallow S Schein J Katz N: Direct costs of opioid abuse in insured population in the United States. J Manag Care Pharm 2005; 11: 469-479
  5. Birnbaum HG White AG Reynolds JL Greenberg PE Zhang M Vallow S Schein JR Katz NP: Estimated cost of prescription opioid analgesic abuse in the Untied States in 2001: a societal perspective. Clin J Pain 2006; 22: 667-676
  6. Fishbain DA: The association of chronic pain and suicide. Semin Clin Neuropsychiatry 1999; 4: 221-227
  7. Compton P Darakjian J Miotto K: Screening for addiction in patients with chronic pain and ‘problematic’ substance use: evaluation of a pilot assessment tool. J Pain Symptom Manage 1998; 16: 355-363
  8. Fishbain DA Rosomoff HL Rosomoff R: Drug abuse, dependence, and addiction in chronic pain patients. Clin J Pain 1992; 8: 77-85
  9. Mendell JR Sahenk Z: Clinical practice: painful sensory neuropathy. N Engl J Med 2003; 348: 1243-1255
  10. Fishbain DA Goldberg M Rosomoff RS Rosomoff H: Completed suicide in chronic pain. Clin J Pain 1991; 7: 29-36
  11. Smith MT Edwards RR Robison RC Dworkin RH: Suicidal ideation, plans and attempts in chronic pain patients: factors associated with increased risk. Pain 2004; 111: 201-208
  12. Braden JB Sullivan MD: Suicidal thoughts and behavior among adults with self-reported pain conditions in the national comorbidity survey replication. J Pain 2008; 9: 1106-1115
  13. Ilgen MA Zivin K McCammon RJ Valenstein M: Pain and suicidal thoughts, plans and attempts in the United States. Gen Hosp Psychiatry 2008; 30: 521-527
  14. Ratcliffe GE Enns MW Belik SL Sareen J: Chronic pain conditions and suicidal ideation and suicide attempts: an epidemiologic perspective. Clin J Pain 2008; 24: 204-210
  15. Fishbain DA Bruns D Disorbio JM Lewis JE: Risk for five forms of suicidality in acute pain patients and chronic pain patients vs pain-free community controls. Pain Med 2009; 10: 1095-1105
  16. Tracey I Bushnell MC: How neuroimaging studies have challenged us to rethink: is chronic pain a disease?. J Pain 2009; 10: 1113-1120
  17. Portenoy RK Lesage P: Management of cancer pain. Lancet 1999; 353: 1695-1700
  18. Fairchild A: Under-treatment of cancer pain. Curr Opin Support Palliat Care 2010; 4: 11-15
  19. Deandrea S Montanari M Mojal AP Apolone G: Prevalence of undertreatment of cancer pain: a review of published literature. Ann Oncol 2008; 19: 1985-1991
  20. Portenoy RK Foley KM: Chronic use of opioid analgesics in non-malignant pain: report of 38 cases. Pain 1986; 25: 171-186
  21. Joranson DE Gilson AM: State intractable pain policy: current status. Aust Prosthodont Soc Bull 1997; 7: 7-9
  22. Portenoy RK: Opioid therapy for chronic nonmalignant pain: a review of the critical issues. J Pain Symptom Manage 1996; 11: 203-217
  23. American Academy of Pain Management and the American Pain Society The use of opioids for the treatment of chronic pain: a consensus document. Glenview, American Academy of Pain Management and the American Pain Society. 1997;
  24. Savage S: Opioid use in the management of chronic pain. Med Clin North Am 1999; 83: 761-785
  25. Ballantyne JC Mao J: Opioid therapy for chronic pain. N Engl J Med 2003; 349: 1943-1953
  26. Fishbain DA Cole B Lewis J Rosomoff HL Rosomoff RS: What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. Pain Med 2008; 9: 444-459
  27. Johnston LD O’Malley PM Bachman JG Schulenberg JE: Monitoring the Future. National Survey Results on Drug Use, 1975-2008 1: Secondary School Students. NIH Publ No 09-7402. Bethesda, National Institute on Drug Abuse 2009;
  28. Johnston LD O’Malley PM Bachman JG Schulenberg JE: Monitoring the Future. National Survey Results on Drug Use, 1975-2008 2: College Students and Adults Ages 19-50. NIH Publ No 09-7403. Bethesda, National Institute on Drug Abuse 2009;
  29. Novak S Nemeth WC Lawson KA: Trends in medical use and abuse of sustained-release opioid analgesics: a revisit. Pain Med 2004; 5: 59-65
  30. Cicero TJ Inciardi JA: Diversion and abuse of methadone prescribed for pain management. JAMA 2005; 293: 297-298
  31. Volkow ND: Prescription drugs, abuse and addiction. NIH Publ No 01-4881, rev. Bethesda, National Institute on Drug Abuse 2005;
  32. Treatment Episode Data Set (TEDS) Highlights 2007. National Admissions to Substance Abuse Treatment Services. DASIS Series: S-45. DHHS Publication No (SMA) 09-4360 Rockville, Substance Abuse and Mental Health Services Administration, Office of Applied Studies 2009;
  33. Johnston LD O’Malley PM Bachman CG Schulenberg JE: Monitoring the Future. National Survey Results on Drug Abuse, 1975-2007 1: Secondary School Students. NIH Publ No 08-6418a. Bethesda, National Institute on Drug Abuse 2008;
  34. Sproule B Brands B Li S Catz-Biro L: Changing patterns in opioid addiction: characterizing users of oxycodone and other opioids. Can Fam Physician 2009; 55: 68-69 69e1-e5
  35. Drug Abuse Warning Network, 2006 National Estimates of Drug-Related Emergency Department Visits. DAWN Series D-30. DHHS Publ No (SMA) 08-4339. Rockville, Substance Abuse and Mental Health Services Administration, Office of Applied Studies 2008;
  36. Paulozzi LJ Budnitz DS Xi Y: Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf 2006; 15: 618-627
  37. Paulozzi LJ: Opioid analgesic involvement in drug abuse deaths in American metropolitan areas. Am J Public Health 2006; 96: 1755-1757
  38. Martell BA O’Connor PG Kerns RD Becker WC Morales KH Kosten TR Fiellin DA: Systematic review - opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med 2007; 146: 116-127
  39. Katz N Sherburne S Beach M Rose RJ Vielguth J Bradley J Fanciullo GJ: Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy. Anesth Analg 2003; 97: 1097-1102
  40. Ives TJ Chelminski PR Hammett-Stabler CA Malone RM Perhac JS Potisek NM Shilliday BB DeWalt DA Pignone MP: Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. BMC Health Serv Res 2006; 6: 46
  41. Reid MC Engles-Horton LL Weber MB Kerns RD Rogers EL O’Connor PG: Use of opioid medications for chronic noncancer pain syndromes in primary care. J Gen Intern Med 2002; 17: 173-179
  42. Ballantyne JC LaForge KS: Opioid dependence and addiction during opioid treatment of chronic pain. Pain 2007; 129: 235-255
  43. Michna E Jamison RN Pham LD Ross EL Janfaza D Nedeljkovic SS Narang S Palombi D Wasan AD: Urine toxicology screening among chronic pain patients on opioid therapy: frequency and predictability of abnormal findings. Clin J Pain 2007; 23: 173-179
  44. Turk DC Swanson KS Gatchel RJ: Predicting opioid misuse by chronic pain patients: a systematic review and literature synthesis. Clin J Pain 2008; 24: 497-508
  45. Noble M Treadwell JR Tregear SJ Coates VH Wiffen PJ Akafomo C Schoelles KM: Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev 2010; CD006605
  46. Kalso E Edwards JE Moore RA McQuay HJ: Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 2004; 112: 372-380
  47. Eriksen J Sjøgren P Bruera E Ekholm O Rasmussen NK: Critical issues in opioids in non-cancer pain: an epidemiological study. Pain 2006; 125: 172-179
  48. Chou R Fanciullo GJ Fine PG Adler JA Ballantyne JC Davies P Donovan MI Fishbain DA Foley KM Fudin J Gilson AM Kelter A Mauskop A O’Connor PG Passik SD Pasternak GW Portenoy RK Rich BA Roberts RG Todd KH Miaskowski C: Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009; 10: 113-130
  49. Vaillant GE: Natural history of addiction and pathways to recovery. (eds) Graham AW Schultz TK Mayo-Smith MF Ries RK Wilford BB: Principles of Addiction Medicine 3. Chevy Chase, American Society of Addiction Medicine, 2003; 3
  50. Enoch M Goldman D: Genetics of alcoholism and substance abuse. Psychiatr Clin North Am 1999; 22: 289-299
  51. Compton WM Thomas Y Stinson F Grant B: Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2007; 64: 566-576
  52. Swendsen J Conway KP Degenhardt L Glantz M Jin R Merikangas KR Sampson N Kessler RC: Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey. Addiction 2010; 105: 1117-1128
  53. US Department of Justice Office of Diversion Control Automation of reports and consolidated order system. 2006;
  54. Results from the 2006 National Survey on Drug Use and Health National Findings. NSDUH Series H-32. DHHS Publ No SMA 07-4293. Rockville, Substance Abuse and Mental Health Services Administration, 2007;
  55. Gallagher RM Verma S: Managing pain and comorbid depression: a public health challenge. Semin Clin Neuropsychiatry 1999; 4: 203-220
  56. Kroenke K Price RK: Symptoms in the community: prevalence, classification, and psychiatric comorbidity. Arch Intern Med 1993; 153: 2474-2480
  57. Bair MJ Robinson R Katon W Kroenke K: Depression and pain comorbidity: a literature review. Arch Intern Med 2003; 163: 2433-2445
  58. Magni G Marchetti M Moreschi C Merskey H Luchini S: Chronic musculoskeletal pain and depressive symptoms in the National Health and Nutrition Examination. 1. Epidemiologic follow-up study. Pain 1993; 53: 163-168
  59. Miller LR Cano A: Comorbid chronic pain and depression: who is at risk?. J Pain 2009; 10: 619-627
  60. Asmundson GJ Katz J: Understanding the co-occurrence of anxiety disorders and chronic pain: state-of-the-art. Depress Anxiety 2009; 26: 888-901
  61. Villano C Rosenblum A Magura S Fong C Cleland C Betzler TF: Prevalence and correlates of posttraumatic stress disorder and chronic pain in psychiatric outpatients. J Rehabil Res Dev 2007; 44: 167-178
  62. Benedikt RA Kolb LC: Preliminary findings on chronic pain and posttraumatic stress disorder. Am J Psychiatry 1986; 143: 908-910
  63. Meltzer-Brody S Leserman J Zolnoun D Steege J Green E Teich A: Trauma and posttraumatic stress disorder in women with chronic pelvic pain. Obstet Gynecol 2007; 109: 902-908
  64. McFarlane AC Atchison M Rafalowicz E Papay P: Physical symptoms in posttraumatic stress disorder. J Psychosom Res 1994; 42: 607-617
  65. Asmundson GJ Norton G Allerdings M Norton P Larson D: Post-traumatic stress disorder and work-related injury. J Anxiety Disord 1998; 12: 57-69
  66. Braden JB Sullivan MD Ray GT Saunders K Merrill J Silverberg MJ Rutter CM Weisner C Banta-Green C Campbell C von Korff M: Trends in long-term opioid therapy for noncancer pain among persons with a history of depression. Gen Hosp Psychiatry 2009; 31: 564-570
  67. Weisner CM Campbell CI Ray GT Saunders K Merrill JO Banta-Green C Sullivan MD Silverberg MJ Mertens JR Boudreau D von Korff M: Trends in prescribed opioid therapy for non-cancer pain for individuals with prior substance use disorders. Pain 2009; 145: 287-293
  68. Sullivan MD Edlund MJ Zhang L Unützer J Wells KB: Association between mental health disorders, problem drug use and regular prescription opioid use. Arch Intern Med 2006; 166: 2087-2093
  69. Manchikanti L Giordano J Boswell MV Fellows B Manchukonda R Pampati V: Psychological factors as predictors of opioid abuse and illicit drug use in chronic pain patients. J Opioid Manag 2007; 3: 89-100
  70. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, ed 4, text rev. Washington, American Psychiatric Association, 2000;
  71. Heit HA: Addiction, physical dependence, and tolerance: precise definitions to help clinicians evaluate and treat chronic pain patients. J Pain Palliat Care Pharmacother 2003; 17: 15-29
  72. O’Brien C Volkow N: What’s in a word? Addiction versus dependence in DSM-V. Am J Psychiatry 2006; 163: 764-765
  73. Upshur CC Luckmann RS Savageau JA: Primary care provider concerns about management of chronic pain in community clinic populations. J Gen Intern Med 2006; 21: 652-655
  74. Fiellin DA O’Connor PG: New federal initiatives to enhance the medical treatment of opioid dependence. Ann Intern Med 2002; 137: 688-692
  75. Kuehn BM: Centers to weave addiction treatment into medical education. JAMA 2007; 297: 1763
  76. American Pain Society Definitions related to the use of opioids for the treatment of pain. A consensus document from the American Academy of Pain Medicine, the American Pain Society, and the American Society of Addiction Medicine. Glenview, American Academy of Pain Medicine, 2001;
  77. Wasan AD Butler SF Budman SH Fernandez K Weiss RD Greenfield SF Jamison RN: Does report of craving opioid medication predict aberrant drug behavior among chronic pain patients?. Clin J Pain 2009; 25: 193-198
  78. Ralphs JA Williams AC Richardson PH Pither CE Nicholas MK: Opiate reduction in chronic pain patients: a comparison of patient-controlled reduction and staff-controlled cocktail methods. Pain 1994; 56: 279-288
  79. Swegle JM Logemann C: Management of common opioid-induced adverse effects. Am Fam Physician 2006; 74: 1347-1354
  80. Andrews CM Krantz MJ Wedam EF Marcuson MJ Capacchione JF Haigney MC: Methadone-induced mortality in the treatment of chronic pain: role of QT prolongation. Cardiol J 2009; 16: 210-217
  81. Chugh SS Socoteanu C Reinier K Waltz J Jui J Gunson K: A community-based evaluation of sudden death associated with therapeutic levels of methadone. Am J Med 2008; 121: 66-71
  82. Krantz MJ Lewkowiez L Hays H Woodroffe MA Robertson AD Mehler PS: Torsade de pointes associated with very-high-dose methadone. Ann Intern Med 2002; 137: 501-504
  83. Budd K: Pain management: is opioid immunosuppression a clinical problem?. Biomed Pharmacother 2006; 60: 310-317
  84. Katz N Mazer NA: The impact of opioids on the endocrine system. Clin J Pain 2009; 25: 170-175
  85. Brennan MJ Lieberman JA: Sleep disturbances in patients with chronic pain: effectively managing opioid analgesia to improve outcomes. Curr Med Res Opin 2009; 25: 1045-1055
  86. Shaw IR Lavigne G Mayer P Choinière M: Acute intravenous administration of morphine perturbs sleep architecture in healthy pain-free young adults: a preliminary study. Sleep 2005; 28: 677-682
  87. Rosenberg J: Sleep disturbances after non-cardiac surgery. Sleep Med Rev 2001; 5: 129-137
  88. Roehrs T Hyde M Blaisdell B Greenwald M Roth T: Sleep loss and REM sleep loss are hyperalgesic Sleep. 2006; 29: 145-151
  89. Baghdoyan HA: Hyperalgesia induced by REM sleep loss: a phenomenon in search of a mechanism. Sleep 2006; 29: 137-139
  90. Webster LR Choi Y Desai H Webster L Grant BJ: Sleep-disordered breathing and chronic opioid therapy. Pain Med 2008; 9: 425-432
  91. Walker JM Farney RJ Rhondeau SM Boyle KM Valentine K Cloward TV Shilling KC: Chronic opioid use is a risk factor for the development of central sleep apnea and ataxic breathing. J Clin Sleep Med 2007; 3: 455-461
  92. Mogri M Desai H Webster L Grant BJ Mador MJ: Hypoxemia in patients on chronic opiate therapy with and without sleep apnea. Sleep Breath 2009; 13: 49-57
  93. Darke S Ross J: The relationship between suicide and heroin overdose among methadone maintenance patients in Sydney, Australia. Addiction 2001; 96: 1443-1453
  94. McGregor C Darke S Ali R Christie P: Experience of non-fatal overdose among heroin users in Adelaide, Australia: circumstances and risk perceptions. Addiction 1998; 93: 701-711
  95. Rossow I Lauritzen G: Balancing on the edge of death: suicide attempts and life-threatening overdoses among drug addicts. Addiction 1999; 94: 209-219
  96. Bohnert AS Roeder K Ilgen MA: Unintentional overdose and suicide among substance users: a review of overlap and risk factors. Drug Alcohol Depend 2010; 110: 183-192
  97. Chu LF Angst MS Clark D: Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations. Clin J Pain 2008; 24: 479-496
  98. Portenoy RK: Opioid therapy for chronic nonmalignant pain: current status. Fields HL Liebeskind JC: Progress in Pain Research and Management 3 1: Pharmacological Approaches to the Treatment of Chronic Pain. New Concepts and Critical Issues. Seattle, IASP 1994; 247-287
  99. Passik S Portenoy R Ricketts P: Substance abuse issues in cancer patients. Part 2. Evaluation and treatment. Oncology 1998; 12: 729-734
  100. Fleming M Davis J Passik S: Reported lifetime aberrant drug-taking behaviors are predictive of current substance use and mental health problems in primary care patients. Pain Med 2008; 9: 1098-1106
  101. Streltzer J Ziegler P Johnson B: American Academy of Addiction Psychiatry Cautionary guidelines for the use of opioids in chronic pain. Am J Addict 2009; 18: 1-4
  102. Gourlay DL Heit HA Almahrezi A: Universal precautions in pain medicine: a rational approach to the treatment of chronic pain. Pain Med 2005; 6: 107-112
  103. Gourlay D Heit H: Universal precautions: a matter of mutual trust and responsibility. Pain Med 2006; 7: 210-211
  104. Gourlay D Heit H: Universal precautions revisited: managing the inherited pain patient. Pain Med 2009; 10: ((suppl 2)) S115-S123
  105. Dunbar S Katz N: Chronic opioid therapy for non-malignant pain in patients with a history of substance abuse: report of 20 cases. J Pain Symptom Manage 1996; 11: 163-171
  106. Webster LR Webster RM: Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the opioid risk tool. Pain Med 2005; 6: 432-442
  107. Friedman R Li V Mehrotra D: Treating pain patients at risk: evaluation of a screening tool in opioid-treated pain patients with and without addiction. Pain Med 2003; 4: 182-185
  108. Wasan AD Butler SF Budman SH Benoit C Fernandez K Jamison RN: Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain. Clin J Pain 2007; 23: 307-315
  109. Wilsey B Fishman SM Tsodikov A Ogden C Symreng I Ernst A: Psychological comorbidities predicting prescription opioid abuse among patients in chronic pain presenting to the emergency department. Pain Med 2008; 9: 1107-1117
  110. Butler SF Budman SH Fernandez K Jamison RN: Validation of a screener and opioid assessment measure for patients with chronic pain. Pain 2004; 112: 65-75
  111. Belgrade M Schamber C Lindgren B: The DIRE score: predicting outcomes of opioid prescribing for chronic pain. J Pain 2006; 7: 671-681
  112. Skinner HA: The drug abuse screening test. Addict Behav 1982; 7: 363-371
  113. Passik S Kirsh KL Whitcomb L Portenoy RK Katz NP Kleinman L Dodd SL Schein JR: A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy. Clin Ther 2004; 26: 552-561
  114. Butler S Budman SH Fernandez KC Houle B Benoit C Katz N Jamison RN: Development and validation of the Current Opioid Misuse Measure. Pain 2007; 130: 144-156
  115. Passik S Kirsh K: Screening for opioid abuse potential. Clin Updates IASP 2008; 16: 1-4
  116. Chou R Fanciullo GJ Fine PG Miaskowski C Passik SD Portenoy RK: Opioids for chronic non-cancer pain: prediction and identification of aberrant drug-related behaviors. A review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain 2009; 10: 131-146
  117. Fishbain DA Cutler RB Rosomoff HL Rosomoff RS: Validity of self-reported drug use in chronic pain patients. Clin J Pain 1999; 15: 184-191
  118. Hitchcock L Ferrell B McCaffery M: The experience of chronic nonmalignant pain. J Pain Symptom Manage 1994; 9: 312-318
  119. Stenager EN Stenager E Jensen K: Attempted suicide, depression and physical diseases: a 1-year follow-up study. Psychother Psychosom 1994; 61: 65-73
  120. Dworkin R Turk DC Farrar JT Haythornthwaite JA Jensen MP Katz NP Kerns RD Stucki G Allen RR Bellamy N Carr DB Chandler J Cowan P Dionne R Galer BS Hertz S Jadad AR Kramer LD Manning DC Martin S McCormick CG McDermott MP McGrath P Quessy S Rappaport BA Robbins W Robinson JP Rothman M Royal MA Simon L Stauffer JW Stein W Tollett J Wernicke J Witter J: IMMPACT Core outcome measures for chronic pain trials: IMMPACT recommendations. Pain 2005; 113: 9-19
  121. Beck A Ward C Mendelson M Mock J Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-571
  122. McNair D Lorr M Droppleman L: Profile of Mood States. San Diego, Educational and Industrial Testing Service, 1971;
  123. Beck A Steer R Brown C: Beck Depression Inventory-Fast Screen for Medical Patients Manual. San Antonio, Psychological Corporation, 2000;
  124. Beck A Steer R Brown C: Beck Depression Inventory, ed 2. San Antonio, Psychological Corporation, 1996;
  125. Zung W: A self-rating depression scale. Arch Gen Psychiatry 1965; 12: 63-70
  126. Radloff L: The CES-D scale: a self-report depression scale for research in the general population. App Psychol Meas 1977; 1: 385-401
  127. Kroenke K Spitzer RL Williams JB: The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16: 606-613
  128. Beck A Epstein N Brown G Steer R: An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988; 56: 893-897
  129. Spielberg C Gorsuch R Iushene R: Manual for the State-Trait Anxiety Inventory. Palo Alto, Consulting Psychologists, 1970;
  130. Bjelland L Dahl A Haug T Neckelman D: The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res 2002; 52: 69-77
  131. Kroenke K Spitzer R Williams J Lowe B: An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics 2009; 50: 613-621
  132. Rickels MR Khalid-Khan S Gallop R Rickels K: Assessment of anxiety and depression in primary care: value of a four-item questionnaire. J Am Osteopath Assoc 2009; 109: 216-219
  133. Manchikanti L Pampati V Damron KS Beyer CD Barnhill RC: Prevalence of illicit drug use in patients without controlled substance abuse and interventional pain management. Pain Physician 2003; 6: 159-166
  134. Reisfield GM Wasan AD Jamison RN: The prevalence and significance of cannabis use in patients prescribed chronic opioid therapy: a review of the extant literature. Pain Med 2009; 10: 1434-1441
  135. Berrocoso E Sánchez-Blázquez P Garzón J Mico JA: Opiates as antidepressants. Curr Pharm Des 2009; 15: 1612-1622
  136. Holbrook TL Galameau M Quinn K Dougherty A: Morphine use after combat injury in Iraq and posttraumatic stress disorder. N Engl J Med 2010; 362: 110-117
  137. Jamison RN Kauffman J Katz NP: Characteristics of methadone maintenance patients with chronic pain. J Pain Symptom Manage 2000; 19: 53-62
  138. Larson MJ Paasche-Orlow M Cheng DM Lloyd-Travaglini C Saitz R Samet JH: Persistent pain is associated with substance use after detoxification: a prospective cohort analysis. Addiction 2007; 102: 752-760
  139. Kouyanou K Pither CE Wessely S: Medication misuse, abuse and dependence in chronic pain patients. J Psychosom Res 1997; 43: 497-504
  140. Trafton JA Oliva EM Horst DA Minkel JD Humphreys K: Treatment needs associated with pain in substance use disorder patients: implications for concurrent treatment. Drug Alcohol Depend 2004; 73: 23-31
  141. Brands B Blake J Sproule B Gourlay D Busto U: Prescription opioid abuse in patients presenting for methadone maintenance treatment. Drug Alcohol Depend 2004; 73: 199-207
  142. Rosenblum A Joseph H Fong C Kipnis S Cleland C Portenoy RK: Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA 2003; 289: 2370-2378
  143. Zacny J Bigelow G Compton P Foley K Iguchi M Sannerud C: College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: position statement. Drug Alcohol Depend 2003; 69: 215-232
  144. Savage SR Kirsh KL Passik SD: Challenges in using opioids to treat pain in persons with substance use disorders. Addict Sci Clin Pract 2008; 4: 4-25
  145. Currie SR Hodgins DC Crabtree A Jacobi J Armstrong S: Outcome from integrated pain management treatment for recovering substance abusers. J Pain 2003; 4: 91-100
  146. Finlayson RE Maruta T Morse RM Martin MA: Substance dependence and chronic pain: experience with treatment and follow-up results. Pain 1986; 26: 175-180
  147. Baron MJ McDonald PW: Significant pain reduction in chronic pain patients after detoxification from high-dose opioids. J Opioid Manag 2006; 2: 277-282
  148. Hewitt DJ: The use of NMDA receptor antagonist in the treatment of chronic pain. Clin J Pain 2000; 16: ((suppl)) 73-79
  149. Graham NA Merlo LJ Goldberger BA Gold MS: Methadone and heroin-related deaths in Florida. Am J Drug Alcohol Abuse 2008; 34: 347-353
  150. Modesto-Lowe V Brooks D Petry N: Methadone deaths: risk factors in pain and addicted populations. J Gen Intern Med 2010; 25: 305-309
  151. Boas RA Villiger JW: Clinical actions of fentanyl and buprenorphine: the significance of receptor binding. Br J Anaesth 1985; 57: 192-196
  152. Heit H Gourlay D: Buprenorphine: new tricks with an old molecule for pain management. Clin J Pain 2008; 24: 93-97
  153. Malinoff H Barkin R Wilson G: Sublingual buprenorphine is effective treatment of chronic pain syndrome. Am J Ther 2005; 12: 379-384
  154. Webster L: Update on abuse-resistant and abusedeterrent approaches to opioid formulations. Pain Med 2009; 10: ((suppl 2)) S124-S133
  155. Katz N: Abuse-deterrent opioid formulations: are they a pipe dream?. Curr Rheumatol Rep 2008; 10: 11-18
  156. Arnold LM Rosen A Pritchett YL D’Souza DN Goldstein DJ Iyengar S Wernicke JF: A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain 2005; 119: 5-15
  157. Mease PJ Russell IJ Kajdasz DK Wiltse CG Detke MJ Wohlreich MM Walker DJ Chappell AS: Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia. Semin Arthritis Rheum 2010; 39: 454-464
  158. Mease PJ Clauw DJ Gendreau RM Rao SG Kranzler J Chen W Palmer RH: The efficacy and safety of milnacipran for treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial. J Rheumatol 2009; 36: 398-409
  159. Arnold LM Russell IJ Diri EW Duan WR Young JP Jr Sharma U Martin SA Barrett JA Haig G: A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia. J Pain 2008; 9: 792-805
  160. Chou R: Pharmacological management of low back pain. Drugs 2010; 70: 385-402
  161. Namaka M Leong C Grossbern TA Klowak M Turcotte D Festahani F Gomori A Intratera H: A treatment algorithm for neuropathic pain: an update. Consult Pharm 2009; 24: 885-902
  162. Woolf CJ Mannion RJ: Neuropathic pain: etiology, symptoms, mechanisms and management. Lancet 1999; 353: 1959-1964
  163. Sindrup SH Jensen TS: Efficacy of pharmacologic treatments of neuropathic pain: an update and effect related to mechanisms of drug action. Pain 1999; 83: 389-400
  164. Kroenke K Bair MJ Damush TM Wu J Hoke S Sutherland J Tu W: Optimized antidepressant therapy and pain self-management in primary care patients with depression and musculoskeletal pain: a randomized controlled trial. JAMA 2009; 301: 2099-2110
  165. Gallagher RM: Pain medicine and primary care: a community solution to pain as a public health problem. Med Clin North Am 1999; 83: 555-583
  166. McCracken LM Turk DC: Behavioral and cognitive-behavioral treatment for chronic pain: outcomes, predictors of outcome, and treatment process. Spine (Phila Pa 1976) 2002; 27: 2564-2573
  167. Gallagher RM: Biopsychosocial pain medicine and mind-brain-body science. Phys Med Rehabil Clin N Am 2004; 15: 855-882
  168. Morley S Eccleston C Williams A: Systematic review and meta-analysis of randomized controlled trials of cognitive behavior therapy and behavior therapy for chronic pain in adults, excluding headache. Pain 1999; 80: 1-13
  169. Fordyce WE: Behavioral Methods in Chronic Pain and Illness. St Louis, Mosby, 1976;
  170. Turk DC Flor H: The cognitive-behavioral approach to pain management. McMahon SB Koltzenburg M: Wall and Melzack’s Textbook of Pain. Philadelphia, Elsevier Churchill Livingston, 2006; 339-348
  171. Thieme K Flor H Turk D: Psychological pain treatment in fibromyalgia syndrome: efficacy of operant behavioural and cognitive behavioural treatments. Arthritis Res Ther 2006; 8: R121
  172. Linton SJ Nordin E: A 5-year follow-up evaluation of the health and economic consequences of an early cognitive behavioral intervention for back pain: a randomized, controlled trial. Spine (Phila Pa 1976) 2006; 31: 853-858
  173. Keefe FJ Caldwell DS: Cognitive behavioral control of arthritis pain. Med Clin North Am 1997; 81: 277-290
  174. Chen E Cole SW Kato PM: A review of empirically supported psychosocial interventions for pain and adherence outcomes in sickle cell disease. J Pediatr Psychol 2004; 29: 1997-2009
  175. Lamb S Hansen Z Lall R Castelnuovo E Withers EJ Nichols V Potter R Underwood MR: Back Skills Training Trial Investigators Group cognitive behavioural treatment for low-back pain in primary care: a randomised controlled trial and cost-effectiveness analysis. Lancet 2010; 375: 916-923
  176. Glombiewski JA Hartwich-Tersek J Rief W: Two psychological interventions are effective in severely disabled, chronic back pain patients: a randomized controlled trial. Int J Behav Med 2010; 17: 97-107
  177. Turner JA Manci L Aaron LA: Short- and long-term efficacy of brief cognitive-behavioral therapy for patients with chronic temporomandibular disorder pain: a randomized, controlled trial. Pain 2006; 121: 181-194
  178. Greco CM Rudy TE Manzi S: Effects of a stress-reduction program on psychological function, pain, and physical function of systemic lupus erythematosus patients: a randomized controlled trial. Arthritis Rheum 2004; 51: 625-634
  179. Tatrow K Montgomery GH: Cognitive behavioral therapy techniques for distress and pain in breast cancer patients: a meta-analysis. J Behav Med 2006; 29: 17-27
  180. Jungquist CR O’Brien C Matteson-Rusby S Smith MT Pigeon WR Zia Y Lu N Perlis ML: The efficacy of cognitive-behavioral therapy for insomnia in patients with chronic pain. Sleep Med 2010; 11: 302-309
  181. Leshner AL: Addiction is a brain disease, and it matters. Science 1997; 278: 45-47
  182. DuPont RL: Addiction: a new paradigm. Bull Menninger Clin 1998; 62: 231-242
  183. O’Brien CP McLellan AT: Myths about the treatment of addiction. Lancet 1996; 347: 237-240
  184. Vaillant GE Clark W Cyrus C Milofsky ES Kopp J Wulsin VW Mogielnicki NP: Prospective study of alcoholism treatment: eight-year follow-up. Am J Med 1983; 75: 455-463
  185. Kaskutas LA: Alcoholics Anonymous effectiveness: faith meets science. J Addict Dis 2009; 28: 145-157
  186. Ferri M Amato L Davoli M: Alcoholics Anonymous and other 12-step programmes for alcohol dependence. Cochrane Database Syst Rev 2006; 3: CD005032
  187. Kim Y Lichtenstein G Waalen J: Distinguishing complementary medicine from alternative medicine. Arch Intern Med 2002; 162: 943
  188. Barry D Beitel M Cutter C Garnet B Joshi D Schottenfeld RS Rounsaville BJ: Allopathic, complementary, and alternative medical treatment utilization for pain among methadone-maintained patients. Am J Addict 2009; 18: 379-385
  189. Bardia A Barton D Prokop LJ Bauer BA Moynihan TJ: Efficacy of complementary and alternative medicine therapies in relieving cancer pain: a systematic review. J Clin Oncol 2006; 24: 5457-5464
  190. Gagnier JJ van Tulder M Berman B Bombardier C: Herbal medicine for low back pain: a Cochrane Review. Spine (Phila Pa 1976) 2007; 32: 82-92
  191. Rubinstein SM van Middelkoop M Kuijpers T Ostelo R Verhagen AP de Boer MR Koes BW van Tulder MW: A systematic review on the effectiveness of complementary and alternative medicine for chronic non-specific low-back pain. Eur Spine J 2010; 19: 1213-1228
  192. De Silva V El-Metwally A Ernst E Lewith G Macfarlane GJ: Arthritis Research Campaign Working Group on Complementary and Alternative Medicines: Evidence for the efficacy of complementary and alternative medicines in the management of fibromyalgia: a systematic review. Rheumatology (Oxford) 2010; 49: 1063-1068
  193. Fleming S Rabago D Mundt M Fleming M: CAM therapies among primary care patients using opioid therapy for chronic pain. BMC Complement Altern Med 2007; 7: 15
  194. Koob GF le Moal M: Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 2001; 24: 97-129

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50